BCM
Bayesian Capital Management Portfolio holdings
AUM
$633M
1-Year Return
38.33%
This Quarter Return
+17.28%
1 Year Return
+38.33%
3 Year Return
+146.47%
5 Year Return
+216.79%
10 Year Return
–
AUM
$942M
AUM Growth
+$65.9M
(+7.5%)
Cap. Flow
-$1.44M
Cap. Flow
% of AUM
-0.15%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
1,095
New
434
Increased
124
Reduced
144
Closed
391
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$21.5M |
| 2 |
Alibaba
BABA
|
+$19.7M |
| 3 |
Qualcomm
QCOM
|
+$16M |
| 4 |
Datadog
DDOG
|
+$11.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$9.32M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$20.6M |
| 2 |
Palo Alto Networks
PANW
|
+$20M |
| 3 |
Walt Disney
DIS
|
+$11.8M |
| 4 |
Skyworks Solutions
SWKS
|
+$9.77M |
| 5 |
Nike
NKE
|
+$9.74M |
Sector Composition
| 1 | Technology | 26.34% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Healthcare | 12.91% |
| 4 | Financials | 8.56% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUYA
676
Huya Inc
HUYA
$774M
| $58.1K | 0.01% |
+15,874
| New | +$58.1K |
|
|
FSR
677
DELISTED
Fisker Inc.
FSR
| $52K | 0.01% |
29,700
-203,300
| -87% | -$356K |
|
678
Lexicon Pharmaceuticals
LXRX
$392M
| $49.1K | 0.01% |
+32,119
| New | +$49.1K |
|
|
LILM
679
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $45.4K | ﹤0.01% |
38,450
-67,400
| -64% | -$79.5K |
|
680
Tilray
TLRY
$1.23B
| $43K | ﹤0.01% |
18,700
-188,939
| -91% | -$435K |
|
|
ME
681
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $40K | ﹤0.01% |
+2,190
| New | +$40K |
|
682
CorMedix
CRMD
$952M
| $39.6K | ﹤0.01% |
+10,519
| New | +$39.6K |
|
|
SLGC
683
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $38.2K | ﹤0.01% |
+15,087
| New | +$38.2K |
|
684
RLX Technology
RLX
$3.3B
| $36.8K | ﹤0.01% |
+18,400
| New | +$36.8K |
|
|
ORLA
685
Orla Mining
ORLA
$3.78B
| $36.1K | ﹤0.01% |
+11,100
| New | +$36.1K |
|
686
Heron Therapeutics
HRTX
$199M
| $34.5K | ﹤0.01% |
+20,300
| New | +$34.5K |
|
687
X4 Pharmaceuticals
XFOR
$76.1M
| $33K | ﹤0.01% |
+1,313
| New | +$33K |
|
|
AMRN
688
Amarin Corp
AMRN
$306M
| $29.6K | ﹤0.01% |
+1,700
| New | +$29.6K |
|
689
Lloyds Banking Group
LYG
$64.9B
| $29.4K | ﹤0.01% |
+12,300
| New | +$29.4K |
|
|
PFIE
690
DELISTED
Profire Energy, Inc
PFIE
| $28.9K | ﹤0.01% |
+15,952
| New | +$28.9K |
|
691
Mersana Therapeutics
MRSN
$35.1M
| $27.6K | ﹤0.01% |
+476
| New | +$27.6K |
|
|
MTTR
692
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $26.9K | ﹤0.01% |
10,000
-100
| -1% | -$269 |
|
693
Rigetti Computing
RGTI
$4.91B
| $25K | ﹤0.01% |
25,400
-8,300
| -25% | -$8.18K |
|
694
Rackspace Technology
RXT
$347M
| $21.2K | ﹤0.01% |
10,611
-31,089
| -75% | -$62.2K |
|
|
QVCGA
695
QVC Group, Inc. Series A Common Stock
QVCGA
$79M
| $19.1K | ﹤0.01% |
+436
| New | +$19.1K |
|
696
Aclaris Therapeutics
ACRS
$225M
| $18.7K | ﹤0.01% |
+17,800
| New | +$18.7K |
|
697
Rigel Pharmaceuticals
RIGL
$733M
| $16.5K | ﹤0.01% |
1,138
-370
| -25% | -$5.37K |
|
|
TSP
698
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $15.2K | ﹤0.01% |
17,300
-8,000
| -32% | -$7.02K |
|
699
Precigen
PGEN
$1.24B
| $15.1K | ﹤0.01% |
+11,300
| New | +$15.1K |
|
700
D-Wave Quantum
QBTS
$5.27B
| $14.3K | ﹤0.01% |
+16,200
| New | +$14.3K |
|